News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Innovative Enhanced Medication Therapy Management Model: MedWise Risk Score, Medication Safety Review, and Health Care Outcomes

Association of the MedWise Risk Score With Health Care Outcomes

ByVeronique Michaud, BPharm, PhD,Matt K. Smith, PhD,Ravil Bikmetov, PhD,Pamela Dow, MS,Joshua Johnson, PharmD, BCGP,Alan Stein, MD, PhD,Stephanie Finnel, PhD,Huaichuan Jin, MS,Jacques Turgeon, BPharm, PhD

September 16th 2021

Medication-Related Problems Identified by Pharmacists in an Enhanced Medication Therapy Management Model

ByDavid Bankes, PharmD, BCGP,Katie Pizzolato, PharmD,Stephanie Finnel, PhD,Michael S. Awadalla, PharmD, BCGP,Alan Stein, MD, PhD,Joshua Johnson, PharmD, BCGP,Jacques Turgeon, BPharm, PhD

September 16th 2021

Health Outcomes From an Innovative Enhanced Medication Therapy Management Model

ByAlan Stein, MD, PhD,Stephanie Finnel, PhD,David Bankes, PharmD, BCGP,Huaichuan Jin, MS,Michael S. Awadalla, PharmD, BCGP,Joshua Johnson, PharmD, BCGP,Jacques Turgeon, BPharm, PhD

September 16th 2021

eAppendix: Association of the MedWise Risk Score With Health Care Outcomes

September 16th 2021

eAppendix: Medication-Related Problems Identified by Pharmacists in an Enhanced Medication Therapy Management Model

September 16th 2021

eAppendix: Health Outcomes From an Innovative Enhanced Medication Therapy Management Model

September 16th 2021

Innovative Enhanced Medication Therapy Management Model: MedWise Risk Score, Medication Safety Review, and Health Care Outcomes - Participating Faculty

September 16th 2021

Trending on AJMC

5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug

GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis

Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care

MDS/MPN Response Criteria Tied to Survival

ICER Draft Flags High Cost of New Hypertension Drug Class